Why Patent Protection is key to Commercialising Repurposed Drugs

Without patent protection, efforts to commercialise a repurposed drug have little chance for a reasonable return and are unlikely to attract outside investment.  Repurposing drugs can be extremely fruitful for companies as long as proper patent protection is in place.  There are a few barriers to consider when trying to patent protect repurposed drugs:

• The issue of novelty
• An obviousness rejection and the use of “unexpected results”
• “Composition of matter” patent vs “method of use patent”

Join this panel discussion to discuss these issues, and how best to maximise your return on repurposed drugs. 

Join this complimentary session on April 8 at 5pm BST/12pm ET

Register